Skip to main content
589 results

PCRS believe that it is the responsibility of every healthcare professional to treat tobacco dependency systematically and effectively. PCRS advocate that people wishing to quit using tobacco should be offered the most effective but also the least harmful methods first to support a quit attempt.

PCRS recognises a need for improvement in the timely diagnosis of people living with chronic breathlessness and generally welcomes the NHS England diagnostic pathway support tool. PCRS has some concerns that a diagnostic algorithm can communicate an oversimplification of diagnosis.

Did you wish you had attended the 2023 conference but simply couldn’t afford it? Were you unable to get the time off as your colleague was already booked for annual leave? When you looked into it the train fare and hotel prices were they way too expensive?

Concerns about the environmental impact of the propellant gases used in pressurised metered dose inhalers (pMDIs) and the plastics used in all single-use inhaler devices have made them an important focus for efforts to reduce the environmental impact of the NHS.

The UK's leading respiratory conference for clinicians working primary, community and integrated care returns to Telford in September 2024. Save the date 19th - 21st September 2024 Telford International Centre

The Medicines and Healthcare Products Regulatory Agency (MHRA) has for the first time approved the use of a dual (ICS/Formoterol) combination treatment to be used as a reliever therapy for people aged 12 and over with the therapy choice situated early in the asthma treatment pathway as an alterna

PCRS advocate a pragmatic approach to the pharmacological management of patients with COPD guided by the predominance of breathlessness and/or exacerbations and the presence or absence of comorbid asthma.

Biologics are a class of medications that are specifically designed to target and modify specific components

A new report is showcasing the impact of a national AHSN Network programme to improve access to FeNO testing for asthma diagnosis.

Dr Iain Small (Chair of the Primary Care Respiratory Society 2008 – 2013) (Born 11/02/1961 Died 20/06/2023)

Lung Volume Reduction (LVR) is a clinically proven and NICE approved therapy for reducing breathlessness in COPD. Changes in treatment means that minimally invasive options (e.g. valves) are now available, but the majority of eligible patients are not referred.

Viv Marsh (Asthma Nurse Specialist) is joined by Amanda Roberts (PCRS Patient Reference Group and PCRS Education Committee Patient Representative) to discuss all things Asthma Action Plans in this episode of the PCRS Podcast.